teratogen

Essential Reads: Prenatal Exposure to Valproate and Risk of Neurodevelopmental Disorders in Offspring

Prenatal exposure to valproate is linked to increased risk of autism spectrum disorder, ADHD, lower IQ, and intellectual disability, especially at higher doses.

By |2025-10-09T10:59:46-04:00September 30th, 2025|Essential Reads, Medications and Pregnancy|Comments Off on Essential Reads: Prenatal Exposure to Valproate and Risk of Neurodevelopmental Disorders in Offspring

Essential Reads: Why Non-Randomized Studies Fall Short When Assessing Reproductive Safety

All of our information on the reproductive safety of medications comes from non-randomized studies. However, many of these studies fail to take into consideration other factors associated with maternal psychiatric illness which may also affect outcomes.

By |2022-12-06T12:18:54-04:00December 1st, 2022|Essential Reads, Psychiatric Disorders During Pregnancy, Risk of Malformations|Comments Off on Essential Reads: Why Non-Randomized Studies Fall Short When Assessing Reproductive Safety

Assessing the Reproductive Safety of Antidepressants: Can Non-Randomized Studies Provide the Information We Need?

Perinatal psychiatry is a field in which we treat vulnerable patients, a mother and her child, where both the illness we are treating and the treatments we prescribe have the potential to affect the outcome.  [...]

By |2020-09-09T17:43:09-04:00September 3rd, 2020|Antidepressants, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Assessing the Reproductive Safety of Antidepressants: Can Non-Randomized Studies Provide the Information We Need?

Clinical Update 2020: New Data on Duloxetine and Pregnancy

A few weeks ago, we published a clinical update for duloxetine (Cymbalta) and pregnancy, stating that there was little new to report since we last covered the topic in 2015.  It is somewhat amusing [...]

By |2020-08-13T14:28:20-04:00March 6th, 2020|Antidepressants, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Clinical Update 2020: New Data on Duloxetine and Pregnancy

Clinical Update 2020: Duloxetine and Pregnancy

Women face difficult choices when deciding whether or not to continue psychiatric medications during pregnancy.  For many years, we have typically recommended the older antidepressants, including the selective serotonin reuptake inhibitors or SSRIs such [...]

By |2020-08-10T12:44:33-04:00February 25th, 2020|Antidepressants, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Clinical Update 2020: Duloxetine and Pregnancy
Go to Top